Company profile: PharmaLex
1.1 - Company Overview
Company description
- Provider of specialized services for pharma, biotech and medtech, from early strategic planning and non-clinical requirements through discovery and clinical development, regulatory submissions and commercialization, to post-approval maintenance. Offerings include integrated product development, market access, post-launch outsourcing to optimize compliance and global market coverage, local affiliate support, AI/ML-driven innovation, and PharmaLearn training.
Products and services
- Innovations to Market: Architects paths from regulatory submission to commercialization, orchestrating market access strategy and execution to enable launches and uptake
- Regulatory-focused
- Integrated Product Development: Engineers development of drugs, biologics, and medical devices from discovery through clinical phases, delivering strategic and scientific consulting to shape plans and evidence
- Scientifically-driven
- Post-launch Outsourcing: Constructs global programs that optimize product compliance and market coverage, managing post-approval activities and ongoing maintenance to sustain availability
- Global-scale
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to PharmaLex
Perigord
HQ: Ireland
Website
- Description: Provider of best-in-class labeling artwork to life science companies, with unparalleled expertise in highly regulated sectors, and developer of the world’s only dedicated Pharmaceutical Artwork Management System, GLAMS.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Perigord company profile →
IDEA Pharma
HQ: United States
Website
- Description: Provider of strategic marketing, portfolio and disease area strategy, positioning, scenario planning and communication strategy for pharmaceutical companies, including path-to-market strategies addressing clinical, regulatory and commercial challenges; innovation strategy; strategic pharmaceutical positioning; Immersion, Design, Evaluation, Acceleration insights; and the annual Pharmaceutical Innovation and Invention Index.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IDEA Pharma company profile →
Lucy Scientific
HQ: Canada
Website
- Description: Provider of research, development, and manufacturing of controlled psychotropic drugs, offering targeted formulations, single molecule fractions, crude extracts, raw materials, and white- and private-label products to support mental research and the creation of psychotropic and psychedelic therapeutics across organic, synthetic, and biosynthetic categories.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lucy Scientific company profile →
Natural Pharmaceuticals
HQ: Poland
Website
- Description: Provider of science- and technology-driven health offerings focused on the Omega-3 segment; a Norwegian market leader dedicated to raising awareness among Central European consumers of the health benefits of diets rich in fish and marine fatty acids.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Natural Pharmaceuticals company profile →
The Medicine Maker
HQ: United Kingdom
Website
- Description: Provider of a publication for persons involved in the development and manufacture of pharmaceuticals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full The Medicine Maker company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for PharmaLex
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to PharmaLex
2.2 - Growth funds investing in similar companies to PharmaLex
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for PharmaLex
4.2 - Public trading comparable groups for PharmaLex
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →